Inventor · disambiguated record
Ana-Lucia Relo
Also filed as: RELO ANA · RELO ANA LUCIA
23 granted patents·13 pending applications·57 citations·filing 2008–2019
93Inventor score
Top patents by PatentIndex Score
36 records- 0190US8076326B2N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted Dec 13, 2011·23 cites·28 claims
- 0287US10118926B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 6, 2018·10 cites·6 claims
- 0383US8183237B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2010·Granted May 22, 2012·4 cites·17 claims
- 0480US8343959B2N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2011·Granted Jan 1, 2013·5 cites·10 claims
- 0575US9169253B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 27, 2015·1 cites·23 claims
- 0675US8710059B2N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2011·Granted Apr 29, 2014·3 cites·20 claims
- 0774US8518933B2Modulators of 5-HT receptors and methods of use thereofWANG YING·Filed 2010·Granted Aug 27, 2013·2 cites·9 claims
- 0873US9573950B2Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulatorsABBVIE DEUTSCHLAND·Filed 2015·Granted Feb 21, 2017·2 cites·48 claims
- 0972US8772313B2Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptorHAUPT ANDREAS·Filed 2011·Granted Jul 8, 2014·2 cites·21 claims
- 1072US8362010B2Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorABBOTT GMBH & CO KG·Filed 2010·Granted Jan 29, 2013·2 cites·23 claims
- 1171US8546377B2Modulators of 5-HT receptors and methods of use thereofWANG YING·Filed 2010·Granted Oct 1, 2013·2 cites·17 claims
- 1268US9388148B2Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptorABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 12, 2016·1 cites·6 claims
- 1364US2019048007A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1461US9701679B2Modulators of 5-HT receptors and methods of use thereofABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 11, 2017·0 cites·9 claims
- 1559US2019135777A1Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptorABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1658US9994568B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2015·Granted Jun 12, 2018·0 cites·28 claims
- 1758US8846663B2Modulators of 5-HT receptors and methods of use thereofABBVIE INC·Filed 2013·Granted Sep 30, 2014·0 cites·11 claims
- 1857US2020283439A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 1956US2018127423A1Modulators of 5-ht receptors and methods of use thereofABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 2055US2019071443A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 2153US2018346484A1Modulators of 5-ht receptors and methods of use thereofABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 2252US8492540B21,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptorBRAJE WILFRIED·Filed 2008·Granted Jul 23, 2013·0 cites·20 claims
- 2350US10160744B2Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptorABBVIE DEUTSCHLAND·Filed 2017·Granted Dec 25, 2018·0 cites·17 claims
- 2449US9388141B2Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptorABBVIE DEUTSCHLAND·Filed 2014·Granted Jul 12, 2016·0 cites·27 claims
- 2549US2017158693A1Hexahydrodiazepinoquinolines carrying a cyclic radicalABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 2649US2020002354A1Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disordersABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 2748US2013018047A1N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptorABBOTT LAB·Filed 2012·Application pending·0 cites
- 2848US2017112851A1Hexahydrodiazepinoquinolines carrying a substituted alkyl radicalABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 2947US9879033B2Modulators of 5-HT receptors and methods of use thereofABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 30, 2018·0 cites·9 claims
- 3045US9187483B2Modulators of 5-HT receptors and methods of use thereofAKRITOPOULOU-ZANZE IRINI·Filed 2010·Granted Nov 17, 2015·0 cites·13 claims
- 3144US9540376B2Hexahydrodiazepinoquinolines carrying a substituted alkyl radicalABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 10, 2017·0 cites·36 claims
- 3241US9376396B2Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptorABBVIE DEUTSCHLAND·Filed 2013·Granted Jun 28, 2016·0 cites·29 claims
- 3341US2018339996A1Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disordersABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 3440US2020039930A1Proline amide compounds and their azetidine analogues carrying a specifically substituted benzyl radicalABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 3535US2019062305A1Pyridyl or pyrazinyl compounds carrying a methyl-bound alpha-amino acid amide groupABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 3633US8846951B2Modulators of 5-HT receptors and methods of use thereofAKRITOPOULOU-ZANZE IRINI·Filed 2010·Granted Sep 30, 2014·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Ana-Lucia Relo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →